| Lactose (India) Ltd | 118 Cr. | 94.0 | 137/84.3 | 24.5 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.15 Cr. | 1.65 | 3.69/1.60 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,476 Cr. | 320 | 479/208 | 72.8 | 24.3 | 0.21 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 29.6 Cr. | 39.9 | 79.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 93.0 Cr. | 63.5 | 64.5/17.0 | 372 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 60.7 Cr. | 80.6 | 115/69.7 | 17.3 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 58,591 Cr. | 2,075 | 2,286/1,275 | 21.6 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 282 Cr. | 11.6 | 17.2/10.8 | 16.1 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 883 Cr. | 1,645 | 1,999/635 | 25.9 | 294 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 96.8 Cr. | 19.4 | 29.8/17.0 | 28.0 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 995 Cr. | 338 | 399/219 | 11.2 | 133 | 0.77 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.75 Cr. | 13.1 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.85 Cr. | 3.16 | 6.11/2.11 | 4.46 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 345 Cr. | 355 | 536/211 | 59.0 | 0.00 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,473 Cr. | 1,028 | 1,511/944 | 38.4 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 43.0 Cr. | 0.21 | 1.12/0.20 | 2.84 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 25.5 Cr. | 9.70 | 26.3/9.19 | 12.4 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 7.63 Cr. | 7.56 | 13.0/7.25 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 153 Cr. | 429 | 805/415 | 10.7 | 596 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 77.5 Cr. | 77.5 | 92.5/26.1 | 146 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 11,225 Cr. | 1,073 | 2,150/1,068 | 35.3 | 174 | 0.96 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 5.98 Cr. | 47.5 | 88.7/36.1 | 12.2 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 14.2 Cr. | 95.0 | 153/82.7 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 42.0 Cr. | 76.8 | 144/12.2 | 20.4 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.3 Cr. | 40.1 | 69.0/33.0 | 48.8 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 5.91 Cr. | 19.7 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 7,102 Cr. | 409 | 1,028/353 | 24.2 | 72.4 | 0.29 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 77.0 Cr. | 17.8 | 28.8/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.0 Cr. | 21.6 | 30.0/17.4 | 1,096 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 84,893 Cr. | 2,056 | 2,727/2,012 | 48.0 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 242 Cr. | 420 | 524/241 | 23.2 | 123 | 1.08 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 71.8 Cr. | 50.0 | 51.5/26.7 | 97.0 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 67,553 Cr. | 1,163 | 1,279/994 | 19.2 | 603 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 187 Cr. | 300 | 317/159 | 63.4 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 757 Cr. | 75.6 | 115/68.0 | 18.1 | 32.6 | 1.99 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 30.3 Cr. | 23.2 | 39.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 17,598 Cr. | 2,150 | 2,183/930 | 61.4 | 173 | 0.07 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.76 Cr. | 0.72 | 1.06/0.51 | 68.0 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.5 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.20 Cr. | 14.0 | 19.1/7.60 | 273 | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 123 Cr. | 5.23 | 6.80/2.82 | 286 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 56,026 Cr. | 26,365 | 37,000/26,006 | 36.8 | 1,888 | 1.77 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,246 Cr. | 689 | 972/557 | 28.9 | 226 | 0.74 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 216 Cr. | 76.1 | 100/31.3 | 63.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,217 Cr. | 1,249 | 1,740/752 | | 93.5 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,099 Cr. | 1,360 | 1,870/1,110 | 203 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 919 Cr. | 263 | 330/154 | 21.4 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 66.8 Cr. | 8.06 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 944 Cr. | 706 | 873/278 | 12.3 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,506 Cr. | 356 | 728/350 | 23.8 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,293 Cr. | 915 | 1,402/915 | 18.6 | 768 | 1.08 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,49,552 Cr. | 4,419 | 4,423/2,886 | 64.9 | 250 | 0.74 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 793 Cr. | 86.1 | 179/75.2 | | 41.3 | 0.58 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,217 Cr. | 13.0 | 23.5/11.5 | 17.7 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 11,877 Cr. | 310 | 1,250/303 | 39.5 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,465 Cr. | 149 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,15,901 Cr. | 1,733 | 1,851/1,547 | 34.2 | 324 | 0.92 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,103 Cr. | 473 | 734/440 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,566 Cr. | 381 | 388/175 | 40.8 | 81.2 | 0.11 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,259 Cr. | 320 | 502/260 | 35.3 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,384 Cr. | 4,075 | 6,718/3,966 | 25.4 | 340 | 2.87 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,110 Cr. | 1,880 | 2,725/1,772 | 29.6 | 335 | 1.05 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,550 Cr. | 5,151 | 6,739/4,904 | 29.2 | 373 | 2.40 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 120 Cr. | 33.9 | 76.0/30.6 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,268 Cr. | 5,086 | 5,993/3,701 | 30.6 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 118 Cr. | 96.0 | 122/81.0 | 8.50 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,049 Cr. | 335 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,291 Cr. | 649 | 1,065/604 | 127 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 17,128 Cr. | 13,350 | 19,748/10,060 | 95.6 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 237 Cr. | 12.2 | 30.0/12.2 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,944 Cr. | 946 | 1,060/660 | 11.0 | 483 | 0.65 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,501 Cr. | 45.6 | 70.5/33.5 | 32.8 | 21.8 | 0.42 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,871 Cr. | 174 | 271/156 | 21.8 | 59.3 | 0.46 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 47.6 Cr. | 30.1 | 108/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 218 Cr. | 61.0 | 129/60.7 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,02,899 Cr. | 2,251 | 2,263/1,774 | 20.7 | 430 | 0.54 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,226 Cr. | 612 | 679/440 | 14.0 | 357 | 0.29 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 55,389 Cr. | 1,026 | 1,141/517 | 69.1 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,403 Cr. | 1,352 | 1,599/596 | 24.5 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 129 Cr. | 59.7 | 114/51.0 | | 74.6 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 620 Cr. | 128 | 215/120 | 37.4 | 104 | 2.35 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 561 Cr. | 321 | 500/265 | 21.5 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 13,970 Cr. | 877 | 1,250/802 | 30.3 | 414 | 0.56 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 33,237 Cr. | 2,070 | 2,085/1,303 | 44.1 | 243 | 0.77 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,162 Cr. | 174 | 302/155 | 27.3 | 37.9 | 1.44 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 37,968 Cr. | 1,497 | 1,595/1,168 | 36.0 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,111 Cr. | 71.9 | 127/57.5 | 16.9 | 59.7 | 1.39 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 1,161 Cr. | 142 | 150/67.2 | 24.5 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,857 Cr. | 201 | 350/190 | | 106 | 0.10 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,484 Cr. | 201 | 457/177 | 99.4 | 96.9 | 0.70 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,314 Cr. | 1,545 | 2,350/1,243 | 32.1 | 397 | 0.45 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 2,763 Cr. | 276 | 409/275 | 54.6 | 62.7 | 0.04 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,550 Cr. | 600 | 627/412 | 26.8 | 164 | 0.25 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 57,639 Cr. | 2,042 | 2,286/1,275 | 21.3 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 44,295 Cr. | 2,615 | 3,516/2,220 | 44.0 | 101 | 1.61 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 29,714 Cr. | 1,804 | 2,131/1,200 | 25.1 | 610 | 1.00 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 5,988 Cr. | 368 | 528/355 | 25.8 | 149 | 1.39 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 19,157 Cr. | 1,383 | 1,910/1,097 | 43.2 | 227 | 0.53 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,08,796 Cr. | 1,304 | 1,380/1,020 | 19.5 | 432 | 0.61 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 2,802 Cr. | 179 | 322/176 | 21.2 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,07,233 Cr. | 1,328 | 1,673/1,282 | 22.5 | 408 | 0.98 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 12,986 Cr. | 1,708 | 2,397/1,551 | 21.1 | 416 | 0.35 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 209 Cr. | 71.0 | 166/58.4 | 9.68 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,363 Cr. | 223 | 244/105 | 21.4 | 107 | 0.22 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 55.0 Cr. | 33.8 | 57.2/28.5 | 19.9 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 63,029 Cr. | 389 | 425/291 | 76.8 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,058 Cr. | 1,044 | 2,000/1,030 | 24.6 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 121 Cr. | 76.0 | 129/64.0 | 14.9 | 49.2 | 1.57 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 260 Cr. | 110 | 205/69.9 | 22.7 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,873 Cr. | 8,749 | 10,691/6,502 | 105 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,741 Cr. | 602 | 791/544 | 30.1 | 118 | 0.76 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 136 Cr. | 64.6 | 125/61.0 | 11.5 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 65,416 Cr. | 5,471 | 5,934/4,492 | 27.2 | 1,116 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 14,782 Cr. | 752 | 1,108/725 | 22.3 | 271 | 1.46 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 406 Cr. | 711 | 959/663 | 42.3 | 690 | 0.69 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 36,809 Cr. | 2,946 | 3,021/2,022 | 36.3 | 345 | 0.94 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,478 Cr. | 311 | 367/258 | 24.1 | 133 | 1.73 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,387 Cr. | 371 | 575/312 | 18.2 | 147 | 0.54 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,324.15 Cr | 1,096.80 | | 56.60 | 201.33 | 0.37% | 16.29% | 15.20% | 6.10 |